ArticleFrontiers in microbiology2026
Machine learning increases the prediction of stroke for Chinese hypertensive patients.
Article in Frontiers in microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- An interpretable machine learning model for predicting stroke in patients with hypertension: insights from the SPRINT.Scientific reports · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: We aim to construct a machine learning (ML) model to predict stroke risk in patients with hypertension. Methods: In all, 68 variables, including demographic information, medical history and medication use, lifestyle, anthropometry laboratory tests, electrocardiography, and echocardiography, were selected for baseline analysis. Of these, 10 optimal variables were selected by Recursive feature elimination (RFE) and then the model was trained and tested using eXtreme Gradient Boosting (XGBoost). A 10- fold cycle of cross-validation was used during the process. Next, XGBoost was used to develop a prediction model. Four traditional Cox regression models including the China-PAR Score and the Framingham Stroke Risk Score model were established and compared with the ML model. Finally, the results of the performance assessment of the models were compared using C-statistics for discrimination and Brier score for calibration. Results: In all, we included 5,197 hypertensive participants (mean age = 57.16 ± 10.20 years) from the Northeast China Rural Cardiovascular Health Study (NCRCHS). Of these, end point events occurred in 294 patients (5.7%, 185 males and 109 females) during a mean follow-up period of 4.26 ± 1.03 years. Using RFE, 10 variables were selected to construct the XGBoost model. The ML model demonstrated better discrimination than the best performing Cox regression model [C-statistic 0.967 (95% CI, 0.956, 0.978) vs. 0.781 (95% CI, 0.772, 0.785), respectively] with an acceptable calibration (Brier score = 0.053). Conclusion: Using the ML method, we constructed a high-precision prognostic model to predict stroke risk in patients with hypertension. This model exhibited a better classification effect and better performance compared with the traditional risk scales. The model could be used in clinical practice to achieve early prevention and intervention of stroke.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.